Activation of exhausted T cells using a tolerable and effective conditional 4-1BB agonistic antibody as described herein has the potential to restore their cytotoxic activity and provide an opportunity to overcome exhaustion as part of anti-PD-1 resistance and potentially increase the response rate in T cell infiltrated cancer indications [10, 48]. The gene discussed is PDCD1; the disease is cancer.